X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (17550) 17550
Newsletter (195) 195
Magazine Article (37) 37
Book Chapter (36) 36
Dissertation (9) 9
Newspaper Article (4) 4
Conference Proceeding (3) 3
Book Review (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (14636) 14636
male (9615) 9615
female (8642) 8642
cyclosporine (7766) 7766
adult (6885) 6885
middle aged (6342) 6342
transplantation (6236) 6236
cyclosporine - adverse effects (5134) 5134
immunosuppressive agents - adverse effects (5030) 5030
immunosuppressive agents - therapeutic use (5012) 5012
cyclosporine - therapeutic use (4572) 4572
surgery (3891) 3891
immunology (3271) 3271
treatment outcome (2954) 2954
adolescent (2793) 2793
animals (2734) 2734
aged (2689) 2689
tacrolimus (2367) 2367
cyclosporine - administration & dosage (2347) 2347
immunosuppressive agents - administration & dosage (2248) 2248
kidney transplantation (2203) 2203
cyclosporine-a (2163) 2163
child (2112) 2112
retrospective studies (2032) 2032
immunosuppression (2004) 2004
therapy (1993) 1993
recipients (1973) 1973
drug therapy, combination (1968) 1968
time factors (1925) 1925
pharmacology & pharmacy (1829) 1829
risk factors (1820) 1820
follow-up studies (1655) 1655
kidney transplantation - adverse effects (1641) 1641
urology & nephrology (1624) 1624
graft rejection - prevention & control (1526) 1526
tacrolimus - therapeutic use (1467) 1467
tacrolimus - adverse effects (1348) 1348
kidney transplantation - immunology (1313) 1313
rats (1225) 1225
calcineurin inhibitors (1223) 1223
hematology (1223) 1223
child, preschool (1220) 1220
prospective studies (1165) 1165
mycophenolic acid - analogs & derivatives (1130) 1130
kidneys (1120) 1120
mycophenolate-mofetil (1107) 1107
dose-response relationship, drug (1004) 1004
transplantation, homologous (990) 990
oncology (969) 969
analysis (963) 963
children (960) 960
dermatology (955) 955
young adult (954) 954
pharmacokinetics (919) 919
pediatrics (910) 910
cyclosporine - pharmacology (908) 908
health aspects (906) 906
efficacy (885) 885
medicine & public health (874) 874
disease (864) 864
renal-transplantation (861) 861
mycophenolic acid - therapeutic use (851) 851
immunosuppressive agents (837) 837
care and treatment (830) 830
immunosuppressive agents - pharmacokinetics (819) 819
immunosuppressive agents - pharmacology (814) 814
creatinine - blood (808) 808
sirolimus (806) 806
graft survival (796) 796
immunotherapy (793) 793
gastroenterology & hepatology (792) 792
incidence (789) 789
liver transplantation (784) 784
rejection (772) 772
drug therapy (765) 765
kidney - drug effects (765) 765
drug interactions (754) 754
nephrotoxicity (747) 747
research (747) 747
kidney-transplantation (744) 744
azathioprine - therapeutic use (724) 724
recurrence (718) 718
infant (706) 706
medicine, general & internal (706) 706
cyclosporine - blood (698) 698
methotrexate (691) 691
cyclosporine - pharmacokinetics (687) 687
tacrolimus - administration & dosage (678) 678
corticosteroids (668) 668
acute disease (659) 659
azathioprine (656) 656
drug administration schedule (652) 652
kidney transplantation - physiology (640) 640
graft rejection (635) 635
biopsy (634) 634
fk506 (632) 632
mycophenolate mofetil (627) 627
organ transplant recipients (620) 620
administration, oral (614) 614
chronic disease (613) 613
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (17007) 17007
French (200) 200
German (188) 188
Japanese (170) 170
Spanish (128) 128
Chinese (67) 67
Italian (44) 44
Polish (40) 40
Russian (23) 23
Korean (22) 22
Portuguese (21) 21
Hungarian (13) 13
Czech (8) 8
Norwegian (7) 7
Serbian (6) 6
Danish (5) 5
Dutch (5) 5
Finnish (5) 5
Croatian (3) 3
Lithuanian (2) 2
Swedish (2) 2
Turkish (2) 2
Hebrew (1) 1
Persian (1) 1
Romanian (1) 1
Slovak (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 6, p. e0198184
Background Many patients with immune thrombocytopenia (ITP) may require special attention and long-term treatment. Little is known on the efficacy and... 
AUTOIMMUNE THROMBOCYTOPENIA | TREATMENT OPTIONS | ADULT PATIENTS | INTRAVENOUS GAMMA-GLOBULIN | MANAGEMENT | ANTI-D | MEDICAL THERAPY | SAFETY | PURPURA | ROMIPLOSTIM | MULTIDISCIPLINARY SCIENCES | Prednisolone - adverse effects | Azathioprine - therapeutic use | Pyrazoles - therapeutic use | Benzoates - therapeutic use | Recombinant Fusion Proteins - adverse effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Immunoglobulins, Intravenous - adverse effects | Child, Preschool | Dexamethasone - adverse effects | Male | Dapsone - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - drug therapy | Receptors, Fc - therapeutic use | Splenectomy | Young Adult | Aged, 80 and over | Child | Rituximab - adverse effects | Purpura, Thrombocytopenic, Idiopathic - surgery | Combined Modality Therapy | Remission Induction | Cyclosporine - therapeutic use | Dexamethasone - therapeutic use | Immunoglobulins, Intravenous - therapeutic use | Rho(D) Immune Globulin - adverse effects | Cyclosporine - adverse effects | Adolescent | Rho(D) Immune Globulin - therapeutic use | Dapsone - adverse effects | Benzoates - adverse effects | Recombinant Fusion Proteins - therapeutic use | Thrombopoietin - therapeutic use | Purpura, Thrombocytopenic, Idiopathic - therapy | Rituximab - therapeutic use | Adult | Female | Prednisolone - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Drug Resistance | Pyrazoles - adverse effects | Hydrazines - therapeutic use | Treatment Outcome | Thrombopoietin - adverse effects | Immunosuppressive Agents - adverse effects | Aged | Azathioprine - adverse effects | Hydrazines - adverse effects | Thrombocytopenic purpura | Clinical trials | Treatment outcome | Care and treatment | Analysis | Drugs | Thrombocytopenia | Therapy | Immunoglobulins | Dexamethasone | Intravenous administration | Medical treatment | Patients | Immunosuppressive agents | Bleeding | Medicine | Remission | Clinical medicine | Azathioprine | Drug dosages | Prednisolone
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2014, Volume 70, Issue 1, pp. 168 - 177
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1465-1858, 03/2017, Volume 2017, Issue 10, p. CD011639
Background As part of liver transplantation, immunosuppression (suppressing the host immunity) is given to prevent graft rejections resulting from the immune... 
Liver Transplantation | LIVER TRANSPLANTATION AND RELATED SURGERY (KJJC) (ACCORDING TO NCSP) | Immunosuppressive Agents | Glucocorticoids | Sirolimus | Gastroenterology & hepatology | Liver disorders | Transplantation | Cyclosporine | Mycophenolic Acid | Retreatment | Immunosuppression | Tacrolimus | Maintenance immunosuppression | Bayes Theorem | Transplantation Immunology | Network Meta‐Analysis | Azathioprine | Drug Therapy, Combination | Odds Ratio | Medicine General & Introductory Medical Sciences | Everolimus | TRANSPLANTATION: SOLID ORGAN | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Immunosuppression - methods | Humans | Immunosuppressive Agents - therapeutic use | Immunosuppression - mortality | Immunosuppression - adverse effects | Everolimus - adverse effects | Adult | Everolimus - therapeutic use | Network Meta-Analysis | Glucocorticoids - adverse effects | Sirolimus - adverse effects | Sirolimus - therapeutic use | Liver Transplantation - mortality | Retreatment - statistics & numerical data | Tacrolimus - adverse effects | Cyclosporine - therapeutic use | Mycophenolic Acid - adverse effects | Tacrolimus - therapeutic use | Drug Therapy, Combination - mortality | Mycophenolic Acid - therapeutic use | Cyclosporine - adverse effects | Immunosuppressive Agents - adverse effects | Azathioprine - adverse effects
Journal Article
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 05/2018, Volume 58, Issue 5, pp. 666 - 673
... + GZR had no significant effect on cyclosporine. However, in the presence of cyclosporine, the 24... 
cyclosporine | drug‐drug interactions | tacrolimus | pharmacokinetics | grazoprevir | mycophenolate mofetil | prednisone | elbasvir | drug-drug interactions | EFFICACY | GRAZOPREVIR MK-5172 | SAFETY | COMBINATION THERAPY | LABEL PHASE-2 TRIAL | RIBAVIRIN | HEPATITIS-C VIRUS | GENOTYPE 1 INFECTION | PHARMACOLOGY & PHARMACY | ELBASVIR MK-8742 | TREATMENT-NAIVE PATIENTS | Quinoxalines - adverse effects | Antiviral Agents - pharmacokinetics | Area Under Curve | Humans | Immunosuppressive Agents - pharmacokinetics | Middle Aged | Imidazoles - administration & dosage | Benzofurans - administration & dosage | Male | Imidazoles - pharmacokinetics | Benzofurans - pharmacokinetics | Young Adult | Drug Interactions | Cyclosporine - pharmacokinetics | Adult | Female | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Tacrolimus - administration & dosage | Prednisone - administration & dosage | Quinoxalines - pharmacokinetics | Prednisone - adverse effects | Quinoxalines - administration & dosage | Administration, Oral | Imidazoles - adverse effects | Mycophenolic Acid - pharmacokinetics | Tacrolimus - pharmacokinetics | Tacrolimus - adverse effects | Antiviral Agents - administration & dosage | Benzofurans - adverse effects | Mycophenolic Acid - adverse effects | Antiviral Agents - adverse effects | Cyclosporine - adverse effects | Cyclosporine - administration & dosage | Prednisone - pharmacokinetics | Immunosuppressive Agents - adverse effects | Drug Combinations | Drugs | Mycophenolic acid | Cyclosporins | Transaminase | Viruses | Prednisone | Pharmacology | Hepatitis | Tacrolimus | Mycophenolate mofetil | Hepatitis C virus | Pharmacokinetics | Hepatitis C | Drug dosages | Prednisolone
Journal Article